Cell therapy CK0801 for aplastic anemia
Part of Blood & lymphatic clinical trials.
This study tests an experimental cell therapy called CK0801 for people with aplastic anemia who still need blood transfusions despite prior treatment. The goal is to see if it can help your bone marrow recover and reduce transfusion needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with aplastic anemia.
- You still need blood transfusions after trying at least one previous treatment, or you cannot tolerate standard treatments.
- If you could become pregnant, you must have a negative pregnancy test and agree to follow study procedures.
- You are willing to follow all study visits and long-term follow-up.
- You are willing and able to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a stem cell transplant (from a matched relative, unrelated donor, or half-matched donor) can help adults aged 40–60 with severe aplastic anemia that didn't get better or came back after standard treatments.
This study tests a new medicine called CM313 for people with aplastic anemia that has returned or not responded to other treatments. It aims to see if CM313 can help improve blood cell counts.
This trial tests a new approach: first, you receive a specially engineered immune cell treatment (CD7 CAR-T) to help prepare your body, then a stem cell transplant from a relative. It's designed for people with severe aplastic anemia who cannot have or choose not to get a standard transplant.
This study tests a new antibody drug (anti-CD38) for people with severe aplastic anemia that has not responded to or has come back after standard treatments. The goal is to see if this drug can help improve blood counts when other options have failed.
This trial tests a drug called romiplostim (Nplate) for patients whose aplastic anemia—a rare blood disorder where the bone marrow stops making enough blood cells—didn't improve after cancer treatment and hasn't responded to other medications. The drug may help your bone marrow produce more blood cells.
This trial tests a new way of using a mix of donor stem cells (from a half-matched family member and a cord blood unit) to treat aplastic anemia, a condition where the bone marrow stops making enough blood cells. The goal is to see if this transplant approach is safe and helps rebuild healthy blood cells.
Hear when a new Aplastic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.